Material is the message. This exploration of mind, media and matter, process and substance, is the theme for Wallpaper* and StoneX’s ‘Material Alchemists’ exhibition, running at the Triennale di ...

Novartis is set to invest $23 billion in US-based manufacturing and research and development (R&D) over the next five years, becoming the latest pharmaceutical company to shift operations to the ...

Emily Looker was promoted to executive director of U.S. corporate marketing at Novartis. The Ad Council named 17 new members to its board of directors and elevated Carla Hassan, chief marketing ...

Swiss pharma major Novartis (NOVN: VX) has discontinued development of its experimental treatment QUC398 for knee osteoarthritis, ending hopes for a new therapy in the anti-ADAMTS-5 class. The company ...

But, have you ever wondered: what if I could easily create my own custom wallpaper on my iPhone? This new app has the answer for you. Deco makes personal wallpaper customization accessible and ...

Novartis has terminated a phase 2 trial evaluating an investigational ADAMTS-5 inhibitor for patients with osteoarthritis knee pain. The Big Pharma company discontinued the study testing intra ...

Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

All these new products are bundled with a bunch of gorgeous-looking wallpapers, and the Oppo Pad 4 Pro is no different. Here you can download Oppo Pad 4 Pro wallpapers in high quality. If you like the ...

European drugmaker Novartis (NVS), best known for blockbuster drugs like Entresto, Cosentyx, and Kesimpta, just announced a major U.S. investment. The $200 billion pharma company intends to invest ...

Novartis, a global innovative medicines company, plans to invest $23 billion over five years in U.S.-based infrastructure, ensuring all key Novartis medicines for U.S. patients will be made in the ...

Besides, Novartis, Johnson & Johnson plans to spend $55 billion over four years on domestic manufacturing, research and technology. Merck announced plans to spend $1 billion on a vaccine ...